NCT02743637 A Dose Escalation Study of SDX-7320 in Patients With Advanced Refractory or Late-Stage Solid Tumors Status COMPLETED Phase PHASE1
NCT02699606 A Study to Evaluate the Clinical Efficacy of JNJ-42756493 (Erdafitinib), A Pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, In Asian Participants With Advanced Non-Small-Cell Lung Cancer, Urothelial Cancer, Esophageal Cancer Or Cholangiocarcinoma Status COMPLETED Phase PHASE2
NCT02536586 A Study of LY3023414 in Japanese Participants With Advanced Cancer Status COMPLETED Phase PHASE1
NCT02514603 A Study of Prexasertib (LY2606368) in Japanese Participants With Advanced Cancers Status COMPLETED Phase PHASE1
NCT02473497 Crizotinib (Xalkori) Expanded Access Protocol For The Treatment Of Adult Or Pediatric Patients Status NO_LONGER_AVAILABLE Phase N/A
NCT02450175 Etiology of the Platelet-Cancer Metastatic Pathway - A Study of Inflammatory Markers, Platelet Characteristics and Metastatic Surrogates in Cancer Patients and Controls Status UNKNOWN Phase NA
NCT02440685 A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT02434146 Topical Phenylephrine Solution in Preventing Oral Mucosa in Bone Marrow Transplant Patients Receiving Cyclophosphamide and Total Body Radiation Therapy Status TERMINATED Phase PHASE1/PHASE2
NCT02394821 Odor Management in Fungating Wounds Comparing Metronidazole and Polihexanide Status COMPLETED Phase PHASE3
NCT02377752 A Study of Olaratumab in Japanese Participants With Advanced Cancer Status COMPLETED Phase PHASE1
NCT02354547 A Study of SGT-53 in Children With Refractory or Recurrent Solid Tumors Status SUSPENDED Phase PHASE1
NCT02309164 The Use of Acupuncture for Treatment of Chemotherapy-induced Peripheral Neuropathy (CIPN). Status COMPLETED Phase NA
NCT02304419 A Study of Galunisertib on the Immune System in Participants With Cancer Status COMPLETED Phase PHASE1
NCT02226289 Bevacizumab-containing Regimen for Metastatic Colorectal Cancer Failed to Cytotoxic Treatment Status UNKNOWN Phase PHASE2
NCT02215733 The Use of Angiotensin Receptor Blockers and the Risk of Cancer Status COMPLETED Phase N/A
NCT02154022 Collection of Pharmacokinetic Samples From People With Unanticipated Response, Significant Toxicity or Concern of Future Toxicity Status ENROLLING_BY_INVITATION Phase N/A
NCT02044536 Current Practice Pattern and Effect of Training in Upper Endoscopic Biopsy Status COMPLETED Phase N/A